GW Pharmaceuticals, the English drug maker planning a U.S. initial public offering, is working with outside communications counsel and hired a U.S.-based PR and investor relations exec.GW Adds US IR Exec Ahead of IPO
Wed., Mar. 20, 2013
By Greg Hazley
GW Pharmaceuticals, the English drug maker planning a U.S. initial public offering, is working with outside communications counsel and hired a U.S.-based PR and investor relations exec.Read Full Story in Subscriber Area
Main Category: Financial PR & Investor Relations
Get O'Dwyer's Daily PR News Email Newsletter
More Financial PR & Investor Relations posts from O'Dwyer's:
| • | Collected Strategies Handles Rare Earths DealMon., Apr. 20, 2026
|
Collected Strategies handles media for Stillwater, OK-based USA Rare Earth as it acquires Brazil’s Serra Verde critical minerals miner and processor for $2.8B in cash and stock.| • | Gladstone, FTI Work QXO/TopBuild TransactionMon., Apr. 20, 2026
|
Gladstone Place Partners represents QXO Inc. as it agrees to buy TopBuild Corp., which relies on FTI Consulting, to create North America's second largest publicly traded building products distributor.| • | Joele Frank Works QVC's Chapter 11Fri., Apr. 17, 2026
|
QVC Group is using Joele Frank for strategic communications as the TV home shopping pioneer declares Chapter 11.| • | Publicis Posts 4.5% Q1 Organic GrowthTue., Apr. 14, 2026
|
Publicis Groupe reported 4.5 percent Q1 organic growth in net revenues to $4.1B despite the volatile macro environment.| • | PondelWilkinson Adds Anreder & Co. VeteransTue., Apr. 14, 2026
|
PondelWilkinson, the Los Angeles-based IR and strategic communications shop, has expanded to the East Coast by adding Anreder & Company veterans following the retirement of principal Steven Anreder.
